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Abstract
Background: While cesarean sections (CSs) are a life-saving intervention, an increasing number are performed
without medical reasons in low- and middle-income countries (LMICs). Unnecessary CS diverts scarce resources and
thereby reduces access to healthcare for women in need. Argentina, Burkina Faso, Thailand, and Vietnam are
committed to reducing unnecessary CS, but many individual and organizational factors in healthcare facilities
obstruct this aim. Nonclinical interventions can overcome these barriers by helping providers improve their
practices and supporting women’s decision-making regarding childbirth. Existing evidence has shown only a
modest effect of single interventions on reducing CS rates, arguably because of the failure to design multifaceted
interventions effectively tailored to the context. The aim of this study is to design, adapt, and test a multifaceted
intervention for the appropriate use of CS in Argentina, Burkina Faso, Thailand, and Vietnam.
Methods: We designed an intervention (QUALIty DECision-making—QUALI-DEC) with four components: (1) opinion
leaders at heathcare facilities to improve adherence to best practices among clinicians, (2) CS audits and feedback
to help providers identify potentially avoidable CS, (3) a decision analysis tool to help women make an informed
decision on the mode of birth, and (4) companionship to support women during labor. QUALI-DEC will be
implemented and evaluated in 32 hospitals (8 sites per country) using a pragmatic hybrid effectiveness-
implementation design to test our implementation strategy, and information regarding its impact on relevant
maternal and perinatal outcomes will be gathered. The implementation strategy will involve the participation of
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women, healthcare professionals, and organizations and account for the local environment, needs, resources, and
social factors in each country.
Discussion: There is urgent need for interventions and implementation strategies to optimize the use of CS while
improving health outcomes and satisfaction in LMICs. This can only be achieved by engaging all stakeholders
involved in the decision-making process surrounding birth and addressing their needs and concerns. The study will
generate robust evidence about the effectiveness and the impact of this multifaceted intervention. It will also assess
the acceptability and scalability of the intervention and the capacity for empowerment among women and
providers alike.
Trial registration: ISRCTN67214403
Keywords: Unnecessary cesarean section, Quality of care, Shared decision-making, Nonclinical intervention,
Healthcare organization, Low- and middle-income countries
Background
Despite the short- and long-term risks associated with
cesarean section (CS) [1], the proportion of births by CS
continues to increase [2]. This trend is not confined to
high-income countries, but it widely affects low- and
middle-income countries (LMICs), where the overuse
and underuse of CS coexist, widening health inequalities
and diverting scarce resources [3]. When clinically indi-
cated, a CS can effectively prevent maternal and peri-
natal mortality and morbidity; however, there is no
evidence of the benefits of a CS for women and infants
who do not need the procedure, and as with any surgery,
there are risks associated that are higher in LMIC set-
tings [4–6]. Women with a single fetus in cephalic pres-
entation who have reached at least 37 weeks’ gestation
and with no previous CS—a group considered low risk—
are major contributors to the growing prevalence of CS
[7]. This pattern has also been described in LMICs. Un-
necessary CS may be particularly prevalent among low-
risk women since these women account for approxi-
mately half of all CS.
The present evidence on care for women during child-
birth has been summarized in the World Health
Organization (WHO) recommendations on intrapartum
care for a positive childbirth experience [8] and may en-
hance the appropriate use of CS if used systematically by
healthcare professionals. However, the overuse of CS
can no longer be seen only as the result of suboptimal
clinical practices during childbirth. Nonclinical factors,
such as social, cultural, and organizational influences,
have emerged as potential drivers and need to be consid-
ered to effectively optimize the use of CS [9]. Nonclinical
interventions that address these factors are defined as
those applied independently of a clinical encounter be-
tween a healthcare provider and a woman in the context
of patient medical care and have been shown to safely
reduce CS rates, predominantly in high-income settings
[10]. They may target providers who are involved in CS
decision-making (physicians, nurses, and midwives),
women and families, or healthcare organizations or
facilities.
The effectiveness of nonclinical interventions to reduce
unnecessary CS has also been summarized by the WHO
[10, 11]. Based on randomized controlled trials with mod-
erate- to high-certainty evidence (Table 1), we designed a
multifaceted intervention called QUALI-DEC to improve
decision-making regarding CS (appropriate use of
cesarean section through QUALIty DECision-making by
women and providers), four components constitute
QUALI-DEC: (1) Opinion leaders (OLs) at healthcare fa-
cilities to implement best practices, (2) CS audits and
feedback to help providers identify areas for improve-
ments in medical practices; (3) a decision analysis tool
(DAT) to help women make an informed decision on the
mode of birth, and (4) companionship to support women
during labor. The theoretical framework shown in Fig. 1
and Table 2 describe how these four mutually reinforcing
components may reduce unnecessary CS by improving
Contributions to the literature
 Overuse of cesarean section diverts essential resources and
has a negative impact on maternal or child health.
 Despite the range of evidence-based interventions, the re-
search reported to date has shown only modest effective-
ness in reducing cesarean section rates.
 The QUALI-DEC project acknowledges the multifactorial and
complex nature of overuse of cesarean section.
 It combines different interventions across stakeholders and
focuses on how to best and most effectively implement
them, accounting for the local context.
 The research will add if combination of interventions at
women’s and health systems level can contribute to
optimizing the use of cesarean section and why and how
the intervention works.
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the decision-making of women and providers regarding
the mode of birth.
In this study, we will design, adapt, and evaluate a
strategy to implement the four components of the
QUALI-DEC intervention. Our primary hypothesis is
that the implementation of quality decision-making sup-
ported by a local OL, continuous CS audit and feedback,
use of the DAT during antenatal care, and companion-
ship during labor could reduce CS rates among low-risk
women. The specific objectives of the study are as
follows:
1. To evaluate the QUALI-DEC strategy at the health
professional and health system levels in terms of
participation, acceptability, implementation,
scalability, and empowerment of providers through
the audit approach, costs at the organization level,
and scalability.
2. To evaluate the QUALI-DEC strategy at the
women’s level in terms of participation in activities
targeting them, acceptability, scalability, and the
empowerment of women in decision-making
regarding the planned mode of birth and
satisfaction with care.
3. To assess the effect of the multifaceted intervention
on CS rates and maternal and perinatal outcomes.
4. To conduct extended cost-effectiveness analyses of
implementing QUALI-DEC interventions from
women’s perspective and the health system




We will use a pragmatic hybrid effectiveness-
implementation type III [12] design to test our imple-
mentation strategy while observing and gathering infor-
mation on the QUALI-DEC intervention’s impact on
relevant outcomes. Using a quasi-experimental design
(interrupted time series and before-after study), we will
assess effectiveness and safety outcomes [13, 14]. A
process evaluation will be carried out using mixed quali-
tative and quantitative approaches [15]. We used the
Standards for Reporting Implementation Studies (STaRI)
checklist to report our research protocol [16].
Context
The multifaceted intervention will be implemented in fa-
cilities in Argentina, Burkina Faso, Thailand, and
Vietnam. These four countries illustrate various degrees
of rates in LMICs (Table 3) and present specific chal-
lenges for QUALI-DEC implementation. Within these
Table 1 Published randomized controlled trials with moderate- to high-certainty evidence
Study Study design Type of intervention Overall CS rate in % Relative effect (95% CI)
Intervention Control
Baseline Post Baseline Post
Lomas [12] Cluster RCT Opinion leader education 53.7* 66.8* Not reported
Audit and feedback 69.7* 66.8*
Althabe [13] Cluster RCT Mandatory second opinion 26.3 24.7 24.6 24.9 ARR −1.9 (−3.8 to −0.1)
Chaillet [14] Cluster RCT Audit and feedback 22.5 21.8 23.2 23.5 ARR −1.8 (−3.8 to −0.2)
RCT 8.5** 7.6** 8.5** 9.0** ARR −1.7 (−3.0 to −0.3)
Mansoumi [15] RCT Antenatal education program for physiologic
childbirth
45.0 43.7 RR 1.03 (0.72 to 1.49)
Bergstrom [16] RCT Antenatal education on natural childbirth
preparation with training in breathing and
relaxation techniques
59.9* 63.0* RR 0.95 (0.58 to 1.56)
Fraser [17] RCT Individualized prenatal education and support
program versus written information in pamphlet
21.3 23.7 RR 0.90 (0.74 to 1.11)
Montgomery [18] RCT Computer-based decision aids (information
program, decision analysis)
48.6* 49.6* RR 0.98 (0.82 to 1.18)
Shorten [19] RCT Decision aid booklet during antenatal care 49.4* 52.2* Not reported
Bohren [11] Meta-analysis Companionship during labor 12.3 15.0 RR 0.75 (0.64 to 0.88)
RCT randomized controlled trial with intervention at the woman’s level; cluster-RCT randomized controlled trial with intervention at the hospital or healthcare
provider level
For RCTs, risk ratio (RR) = (mean rate intervention/mean rate control) with 95% confidence intervals
For the meta-analysis of RCTs, the relative effect is the summary risk ratio with 95% confidence intervals
For cluster-RCTs, absolute risk reduction (ARR) = (rate change in the intervention group)—(rate change in the control group) with 95% confidence intervals
*The selected outcome is the elective repeat cesarean section rate among high-risk women (women with previous CS)
**The selected outcome is the overall CS rate among low-risk women (single pregnancy with cephalic presentation without any complication)
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Fig. 1 Quality decision-making (QUALI-DEC) by women and healthcare providers for appropriate use of cesarean section
Table 2 Definition, theory, and assumptions of each component of the QUALI-DEC intervention
Component Definition Theoretical stance Assumption
Opinion leaders [20] Healthcare leaders are identified by their
colleagues or local authorities in participating
healthcare facilities as being respected
clinicians and effective communicators.
Power/interaction model of
interpersonal influence [21]
Adherence to guidelines and clinical audit
are reinforced through the interaction and
influence of reputable culture change agents.
Audit and
feedback [22]
Indications of CS and CS practice among
low-risk women are audited by a local
committee, with timely feedback to all
healthcare professionals.
Constructivist learning [23] The way knowledge is absorbed, processed,
and retained results from cognitive, emotional,
and environmental influences, and change
occurs through the active involvement of
professionals in analyzing their practices.
Decision analysis
tool (DAT) [24]
A meaningful dialog between providers
and women on preferences, options,
concerns, risks and benefits of planned
CS vs. planned vaginal delivery leads to
an informed and more satisfactory
decision for both parties.
Decision theory [25] A decision aid benefits women and healthcare
workers by facilitating a process of informed
decision-making, in the context of improved
knowledge and overt consideration of women’s




Through the process of implementation,
professionals decide on the modification
of existing systems, structures, or tasks
to offer women and their relatives the
possibility of having a companion of
choice during labor and childbirth.
Convoy model of social
relations [25, 26]
Overuse of CS can be prevented by improving
the design of health systems and processes to
better respond and adapt to the needs of
women and their relatives regarding social
support during labor and childbirth.
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four countries, Argentina has the highest level of CS at
the national level and, more generally, of the biomedica-
lization of childbirth. Thailand has very low fertility,
which may add pressure in favor of CS. A favorable so-
cioeconomic context may also facilitate the preference
for CS. Vietnam is interesting for its demographic im-
pact (size of the population) and its performance in
health indicators given its level of national income.
However, the national CS rate has been continuously in-
creasing over the past few decades, exceeding any rea-
sonable level for medical needs and large inequalities in
the use of CS. Burkina Faso has a low CS rate at the na-
tional level that may hide inequalities [17] and that
suggests a great potential for further increase and conse-
quently represents an opportunity to prevent the
phenomenon before it aggravates.
Targeted sites and participants
The study will be conducted from January 2020 to De-
cember 2024, in 32 healthcare facilities (8 per country)
with high CS rates. Facilities were selected purposely
with country investigators to reflect the range of con-
texts, such as secondary and tertiary levels of care, public
and private hospitals, and teaching and nonacademic fa-
cilities (Table 4). The intervention directly targets
healthcare providers involved in obstetric care and all
Table 3 Main health indicators at country level
Indicator, 2017-2019* Argentina Burkina Faso Thailand Vietnam
Population (millions) 44.9 20.3 66.4 95.7
Total fertility rate 2.3 5.3 1.5 2.0
Maternal mortality ratio 39 320 37 43
Neonatal mortality rate 6.4 24.7 5.0 10.6
Institutional delivery rate 100% 80% 99% 94%
Cesarean section rate 36% 3% 33% 27%
Risk of impoverishing expenditure for surgical care 3.9% 75.9% 6.3% 27.4%
GDP per capita (PPP international $) 2018 20,611 1985 19,051 7478
Income group of the country Upper-middle income Lower income Upper-middle income Middle income
*Latest estimation according to the following source of information: (1) WHO Statistical Information System : https://www.who.int/whosis/indicators/en/; (2) World
Bank national accounts data: https://data.worldbank.org/indicator/NY.GDP.PCAP.PP. CD
Maternal mortality ratio: number of maternal deaths per 100,000 live births
Neonatal mortality rate: number of newborn deaths per 1000 live births
Impoverishing expenditure is defined as direct out-of-pocket payments for surgical and anesthesia care which drive people below a poverty threshold (using a
threshold of $1.25 PPP/day).
Risk of impoverishing is the proportion of population at risk of impoverishing expenditure when surgical care is required
Table 4 Characteristics of participating hospitals by country
Characteristic Argentina Burkina Faso Thailand Vietnam
Type of hospital
Public without private ward 8 8 0 2
Public with private wards 0 0 8 4
Private 0 0 0 2
Level of reference
Tertiary 4 2 6 2
Secondary 4 4 2 4
Primary 0 2 0 2
Teaching hospital
Yes 8 3 8 4
No 0 5 0 4
Type of medical records
Electronic 8 0 4 1
Paper-based 0 8 4 7
Range of annual births 1200-5600 2500-6000 2500-7500 2800-42,000
Range of CS rates 23-38% 21-48% 36-56% 23-54%
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women who give birth in the participating hospitals dur-
ing the study period. We have defined providers as ob-
stetricians and nurses/midwives working in the
maternity ward in the study facilities. Women will be eli-
gible if they give birth to a newborn (birthweight ≥ 500 g
in Argentina and Vietnam or ≥ 1000 g in Burkina Faso
and Thailand), alive or dead, and with or without mal-
formations. The intervention does not target patients ad-
mitted for abortion or miscarriage or those who
delivered at home or in another facility that is not a par-
ticipating hospital.
Intervention
A multifaceted intervention was developed based on
existing evidence (Table 1) and WHO recommendations
on nonclinical interventions to reduce unnecessary CS
[18]. Baseline formative research [19] informed by the
ecological framework [9] will be conducted to improve
our understanding of the different levels of factors af-
fecting CS rates and to adapt the multifaceted interven-
tion to each country. The four components of QUALI-
DEC will be implemented simultaneously in each par-
ticipating hospital during the 2-year implementation
period (Fig. 1):
Component 1—opinion leader (OL)—one OL in each
facility has been identified by peers and local authorities.
OLs are gynecologists-obstetricians with proven com-
munication skills and a reputable influence on their col-
leagues. The OLs will take part in a 5-day training
session at the beginning of the implementation period.
This training will include 1 day training for each of the
following topics: (1) mobilizing OLs on the power/inter-
action model of interpersonal influence; (2) selecting
evidence-based clinical protocols for CS decision-
making; (3) audit and feedback including external review
of medical records and use of Robson classification as a
feedback tool; (4) use of decision-analysis tool; and (5)
implementing continuous companionship during labor.
After the initial training, OLs will create local commit-
tees, launch the audit and feedback, and encourage the
use of the DAT and companionship during labor in their
own hospitals. OLs will undergo a refresher 3-day train-
ing session during the 2-year intervention period. The
aim of this session is to refresh OLs’ knowledge, update
them on the use of evidence-based clinical guidelines
and process of the intervention, discuss their roles, share
their experiences, and confirm their capacity to provide
leadership in their clinical settings.
Component 2—audit and feedback (A&F)—audit cy-
cles will be implemented monthly by the local commit-
tees following the different steps presented in Fig. 2.
Local data collectors will prospectively identifies groups
Fig. 2 Audit cycle to change medical practice
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of women who are admitted for childbirth using the
Robson classification system 20. Then, medical records
of low-risk women (Robson group 1 to 4) will be se-
lected to audit the indications for cesarean sections. The
local committee will provide a conclusive analysis that
will be presented to the rest of the medical staff (feed-
back). It will allow for comparison and analysis of
cesarean section rates within and across the different
groups of women, as well as comparisons to other facil-
ities. Additionally, it will help to ensure that cesarean
sections are performed for clinically valid reasons, and
identify priority areas for coaching, training, and support
for healthcare providers.
Component 3—decision analysis tool (DAT)—the
DAT is adapted to each country and developed to be
used during antenatal care (after 28 weeks of gestation)
by women with a singleton pregnancy, without a previ-
ous CS and eligible for a trial of labor. It includes two
sections: (i) an information section, providing a descrip-
tion and an explanation of the risks and benefits of each
mode of birth (planned vaginal birth vs. planned CS);
and (ii) an exercise section, allowing women to clarify
and summarize their values and preferences with their
clinician and indicate what aspects of the mode of birth
are important to them. The DAT will be available as a
paper booklet and an interactive web/smartphone appli-
cation. The DAT is designed to supplement regular
counseling and discussions with healthcare providers.
They will provide detailed, specific, and personal options
and outcomes in order to prepare women to make the
decision about the mode of delivery.
Component 4—companionship during labor—the
companion can be any person chosen by the woman to
provide her with continuous support during labor and
childbirth. This may be someone from the woman’s fam-
ily or social network, such as her spouse/partner, a fe-
male friend or relative, a community member (such as a
female community leader, health worker, or traditional
birth attendant) or a doula (i.e., a woman who has been
trained in labor support but is not part of the healthcare
facility’s professional staff). The QUALI-DEC strategy
will support the use of any type of culturally appropriate
companion who the woman has selected. This compo-
nent will be implemented using a tailored labor compan-
ionship model that will include information on (1)
eligibility criteria for women and companions, (2) identi-
fication of healthcare providers who will invite the
chosen and eligible labor companion from the waiting
area into the labor room, (3) identification of healthcare
providers who will deliver the messages to the laboring
woman and her companion, (4) how many people are
allowed and when they are allowed to act as compan-
ions, (5) how physical space of the labor ward may need
design modifications to accommodate a companion, and
(vi) educational tools for companions on how to support
women during labor and birth.
Implementation strategy
The implementation strategy is aligned within the usual
model of care in participating healthcare facilities. The
main implementers are the local OLs and healthcare
providers who are involved in the program and are sup-
ported by the country-level study coordinator. Formative
research in the baseline period will assess the main
drivers and barriers, and a meeting will be held among
all stakeholders to discuss implementation issues. Parlia-
mentarians and representatives of women’s associations
will be involved in this meeting to consider women’s
views. Then, the intervention will be introduced in each
country with the 5-day training workshop addressed to
OLs. OLs will receive financial incentives during the
intervention period to compensate for the loss of reve-
nues related to the decrease in their clinical activities.
OL supported by local committee will encourage ante-
natal care providers to deliver the DAT booklet to eli-
gible pregnant women. This will require a series of on-
site meetings in all relevant facilities to inform and mo-
tivate providers and to obtain their formal commitment.
In addition, a DAT application will be developed for
smartphones and made available in the settings in which
it is considered culturally appropriate and most accept-
able and convenient for women. Posters will be dis-
played on the wall of the waiting room of antenatal care
centers with the QR code to access the web/smartphone
application. Other information, educational and commu-
nication (IEC) materials, such as flipcharts or posters,
will be developed to facilitate the briefing of healthcare
providers, companions, and laboring women. These IEC
materials will include reminders about the importance
of labor companionship, the role of companions, and the
regulations of the labor wards. The country-level coord-
inator will conduct quarterly visits to each participating
hospital during the 2-year implementation period to
identify further barriers for the implementation process
and possible strategies to overcome those barriers, verify




The primary endpoint measure is the monthly CS rate
in participating hospitals among women with a singleton
pregnancy, with a fetus in cephalic presentation and at
least 37 weeks of gestation, and with no previous CS
(groups 1-4 of the Robson classification). We will use
the Robson classification to monitor CS rates at the hos-
pital level [7, 27, 28]. This system classifies women into
prospective mutually exclusive and totally inclusive
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groups of women based on a few obstetric variables
which are easily obtained and most women themselves
would know. Trained data collectors will gather infor-
mation about each eligible woman using existing routine
health information systems (paper-based or electronic
records). We will consider the monthly rate of CS before
the onset of intervention (12-month period), during the
implementation phase (24-month period), and after the
implementation phase (24-month period) to assess the
effects of the intervention.
As secondary endpoints, the following outcome mea-
sures will be assessed: assisted vaginal delivery; time of
CS (before or during labor); third- or fourth-degree peri-
neal laceration; antibiotics and uterotonics use; transfu-
sion; admission of the mother or the newborn to
intensive care unit; uterine rupture, hysterectomy, ma-
ternal or neonatal death; time of breastfeeding initiation;
woman’s satisfaction with care and her birth experience;
payment for medical care; indirect costs of care for
childbirth (e.g., cost of transportation to hospital); and
loss of earnings. A cross-sectional survey among a repre-
sentative sample of postpartum women will be
established at two time points: at baseline and at the end
of the intervention period. All births occurring in the
participating hospitals during 2 weeks in Argentina and
Burkina Faso and 1 week in Thailand and Vietnam will
be covered in each survey. The data collection includes a
face-to-face interview with women after childbirth and
before they leave the maternity ward (facility-exit inter-
view) and the collection of information from the
women’s medical records, including socioeconomic
characteristics of the mother, reproductive history, ante-
natal and intrapartum care, time and indication of CS, if
any, satisfaction with birth experience, breastfeeding
practices, out-of-pocket costs, maternal and neonatal
outcomes.
Process evaluation
We will use the UK Medical Research Council (MRC)
process evaluation framework [15] to describe how the
intervention works (or does not work) along the pathway
of implementation, including the internal dynamics of
the four components of the QUALI-DEC strategy. The
process evaluation also explores the roles, perceptions,
Fig. 3 Key functions of the process evaluation and the relations among them (adapted from Moore 2015) [15]
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and coping strategies of actors, adaptation of the inter-
ventions based on the local context, and any unintended
effects, with a view to understand the mediating effect of
the context [29]. Figure 3 presents the key functions of
the QUALI-DEC process evaluation and the relations
among them, while Fig. 4 shows the data collection and
analysis methods.
To align the intervention and the implementation
strategy to the local context, we conduct qualitative re-
search, document review at the country level, and a
readiness assessment of each participating facility. The
qualitative research will include semi-structured inter-
views with women, potential companions, and health-
care providers to obtain a comprehensive understanding
of the health system and societal context in each country
[19]. Additional interviews with policy-makers and rep-
resentatives of women’s and professional associations
(gynecologists-obstetricians and nurses/midwives) will
allow us to complete the stakeholder mapping and ana-
lysis. Following the context assessment and in consult-
ation with QUALI-DEC developers and implementers,
we will define assumptions on what may need to happen
(mechanisms of change), and we will hypothesize about
how change will happen at the individual level (health-
care providers, women, and companions), at the
organizational level (healthcare facility), and through the
interaction of participants. Discussions and meetings will
be held by video conference with country researchers
and during face-to-face meetings with high-level stake-
holders and local OLs in each country. To further assess
the potential scalability of the intervention within the
countries, we will include a participative scalability as-
sessment in the in-country meetings to summarize early
opportunities and challenges for scale up [30].
We will construct a theory of change to guide the
process evaluation. We will define indicators of fidelity
(whether the intervention was delivered as intended),
dose (the quantity of intervention implemented), and
reach of intervention (whether women and providers
came into contact with each relevant component of
QUALI-DEC) [15]. These indicators will be measured at
the individual and organizational levels in all facilities
Fig. 4 Data collection and analysis methods for process evaluation
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using quarterly monitoring visits at each hospital and
data from the postpartum cross-sectional survey (pro-
portion of women who used the DAT during antenatal
care or chose a companion during labor).
We will conduct in-depth case studies in a subset of
four hospitals per country to investigate the details of
what worked, why, and why not. Study sites will be pur-
posively selected based on indicators of fidelity, dose,
and reach to reflect the diversity of implementation
across participating hospitals. Structured observations of
each site and on-site meetings will be held with the
members of the local committee, maternity ward staff,
and facility administrator. In-depth interviews with pro-
viders and women will provide more detailed informa-
tion on the perceptions and views of both stakeholders.
The study instrument for IDIs with healthcare providers
will be a semistructured interview guide covering the fol-
lowing topics: communication; interprofessional inter-
action; acceptability of the CS audit and feedback, DAT
and labor companionship; and decision-making, includ-
ing aspects of position/seniority, gender, weighing of al-
ternatives and their implications, and information-
sharing. The study instrument for IDIs with women and
their companions will be a semistructured interview
guide covering the following topics: process of and fac-
tors affecting the decision-making to use DAT and labor
companionship; perceptions of the DAT and labor com-
panionship related to knowledge, experiences, and sup-
port in choosing the mode of childbirth; perceptions and
experiences of the relationship between themselves and
providers; perception and experiences of how use of the
DAT and/or labor companionship influenced trust, self-
esteem, empowerment, and the relationship with pro-
viders. All interviews will take place in a private setting
and will be audio recorded.
Economic evaluation
The cost-effectiveness of the QUALI-DEC intervention
and the financial risk protection provided are important
factors for decision-makers considering implementing
new strategies to reduce unnecessary CS. We will use an
extended cost-effectiveness analysis (ECEA) approach to
evaluate the cost-effectiveness of the QUALI-DEC inter-
vention [31]. The impact of QUALI-DEC will be esti-
mated in three domains across women in distinct wealth
strata: (i) health gains (e.g., reduced CS rates), (ii) women’s
out-of-pocket (OOP) expenditures averted by reducing
unnecessary CS, and (iii) total net cost of the intervention
to the implementer (see Additional files 1, 2 and 3).
Sample size
Limited guidance is available on sample size calculation
for time series analyses, and many of the recommenda-
tions focus on the need for sufficient time points pre-
and postintervention to precisely ascertain trends and
levels [32, 33]. Our analysis on the primary outcome
(monthly CS rates among low-risk women) will include
12 time points preintervention, 24 time points during
the intervention phase, and 24 time points during the
follow-up phase.
The approach for calculating the required number of
participants for the postpartum cross-sectional survey is
used for a “before-after” noncontrolled study design. We
estimated that a sample of 470 women at baseline and
470 women at the end of the intervention period will en-
sure 90% statistical power to detect an effect size of 0.3
standard deviations or greater in satisfaction scores with
a two-sided 5% significance level [34]. The calculation
accounted for the clustered nature of the data by hospi-
tals with a design effect of 2. Allowing for a 20% nonre-
sponse rate, we aim to recruit 564 women in each phase.
The proposed sample size (i.e., 564) can be achieved
with 2 weeks of data collection in Argentina and Burkina
Faso and with 1 week of data collection in Thailand and
Vietnam. This sample size will be for each country and
will allow to draw conclusions independently for each
country and produce individual country interpretations.
We estimated that 3980 births will occur during this
data collection period in all participating hospitals of the
four countries. This overall sample size for the cross-
sectional survey will ensure accurate measurements of
other secondary outcomes (maternal and perinatal mor-
bidity, time of breastfeeding initiation). Estimations of
outcomes at each time point will fluctuate within a 95%
confidence interval with the following bounds: 10% rate
± 1% (example: postpartum hemorrhage); 20% rate ±
1.3% (example: second-degree perineal trauma); 40% rate
± 1.5%; (examples: overall CS rate, breastfeeding within
1 h of birth).
Analysis
Quantitative analysis
We will use different methods to evaluate the effective-
ness of the QUALI-DEC intervention [13, 14]. For the
primary outcome, interrupted time series analysis (ITSA)
based on segmented regression will estimate the mean
changes in the level (immediate change) and trend (sus-
tained change) of monthly CS rates across all participat-
ing hospitals in relation to their baseline level and pre-
existing trend. We will follow the quality criteria pro-
posed by Ramsay et al. for our ITSA to ensure that our
study is adequately reported [35]. For secondary out-
comes, we will use a before and after cross-sectional de-
sign that will include medical records and women’s
interviews. We will compare the outcomes between the
two periods of the cross-sectional survey, adjusting for
hospital and woman characteristics, to evaluate changes
in satisfaction with the birth experience, breastfeeding
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and medical practices, and maternal/perinatal morbidity.
For implementation outcomes, checklist ratings during
monitoring visits will be used to compute average scores
of the fidelity, dose, and reach of the intervention. Para-
metric tests will be used to assess changes over time for
each facility and differences between study sites.
Qualitative analysis
Qualitative data from observations and IDIs will be ana-
lyzed and interpreted using a thematic analysis approach
[36]. Interview transcripts will be analyzed in the local
language at the country level. Final themes and key quo-
tations will be translated into English for sharing with
the researchers of the QUALI-DEC consortium. Frame-
work analysis will be used to provide an in-depth under-
standing of acceptability [37, 38] by providers and
women/companions and the empowerment [39, 40] of
both stakeholders to act on CS decision-making. We will
define acceptability as the perception of providers and
women that the QUALI-DEC intervention is agreeable,
entails an acceptable burden, is ethical and economically
feasible, and leads to positive outcomes. We aim to
understand the extent to which each component of the
intervention and its process are both socially and tech-
nically accepted in each context. Empowerment can be
understood not only as a process but also as an outcome
to assess whether the intervention has helped providers
and women act on CS decision-making. The analysis will
focus on the individual empowerment of women and
providers. We anticipate that our intervention will en-
hance providers’ empowerment by presenting them with
monthly statistics promoting reflexivity on their prac-
tices, and this increased awareness of clinical practices
will, in turn, enhance obstetricians’ and midwives’ sense
of agency and self-determination in deciding on inter-
ventions during labor and delivery. From the women’s
point of view, the study will detail the self-
empowerment and professional support provided to
women to choose the mode of delivery that better suits
their needs. We will analyze the effect of the interven-
tion on women’s self-esteem, knowledge, and sense of
empowerment when deciding on the mode of delivery.
In our analysis of empowerment, particular attention will
be paid to the gender dimension, including the gender
dynamics between different categories of providers and
between providers and women and how gender norms
shape values and decisions related to childbirth.
Subgroup analyses
The integration of quantitative process measures into
outcome datasets will contribute to understanding how
implementation variability affects outcomes (on-treat-
ment analyses) and to testing hypotheses arising from
qualitative analyses. For example, time-series models
with multigroup comparisons will enable us to conduct
formal statistical tests comparing the level and slope of
the primary outcome between different categories of
healthcare facilities reflecting different levels of imple-
mentation, thereby quantifying the variation of effect
size between subgroups [41] and revealing the mecha-
nisms of impact. Additionally, outcomes between
women in different socioeconomic categories (in terms
of education, place of residence, place of birth, and
wealth index) and between periods will be compared to
assess the equity of the QUALI-DEC intervention.
Knowledge transfer
In consultation with key stakeholders in each participat-
ing country, we will develop an innovative evidence-
based knowledge transfer strategy [42, 43], adapted to
each context. The key ingredients of this strategy will be
training, implementation, and evaluation of a knowledge
broker in each country who will facilitate the adaptation,
dissemination, and exploitation of QUALI-DEC findings
by key stakeholders (see Additional files 1, 2 and 3). As
the implementation of knowledge brokering is very in-
novative, it will be the subject of an in-depth evaluation
in order to generate knowledge about its processes and
effectiveness. A specific research protocol for this part of
the QUALI-DEC project will be published later.
Discussion
There is an urgent need for interventions and imple-
mentation strategies that optimize the use of CS while
improving health outcomes and satisfaction in LMICs.
QUALI-DEC aims to test whether the audit and feed-
back, decision aid, and patient-centered care approaches
supported by local OLs improve the quality of decision-
making and perinatal outcomes.
The components of the QUALI-DEC intervention
have been tested in randomized controlled trials (RCTs)
aiming to reduce the overuse of CS [10]. However, the
research reported to date has shown only modest effect-
iveness in reducing CS rates (Table 1). Evidence on the
effect of implementing evidence-based clinical practice
guidelines combined with A&F and opinion leaders was
available from two RCTS, both from Canada [44, 45].
The effect size on CS rates was moderate to low. How-
ever, no research evidence was identified on the accept-
ability or the impact on equity of this type of
intervention. Evidence on the effect of companionship
was available from a meta-analysis of 26 RCTS [11]. The
effect size on CS rates was moderate. A qualitative evi-
dence synthesis identified various factors affecting suc-
cessful implementation and sustainability of labor
companionship [46]. Three RCTs conducted in the UK
[47], Australia [48], and the USA [49] found that
decision-support tools improved women’s knowledge
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and reducing decisional conflict about mode of delivery
options, but had variable effects on their uptake of trial
of labor or vaginal birth after cesarean section. However,
there are no published randomized trials on the effect of
decision aids on women without a previous cesarean
section. A qualitative evidence synthesis suggests that
women welcome new information and learning about
childbirth which can mediate pregnant women’s con-
cerns about risk. Women perceive educational interven-
tions and decision-aid tools as a “starting point,” a
springboard for seeking more information and for a
more meaningful dialog with health professionals [50].
The reasons behind the limited success of nonclinical
interventions to reduce unnecessary CS include the fail-
ure to acknowledge the multifactorial and complex na-
ture of CS overuse and, accordingly, the failure to design
multifaceted interventions. In addition, not enough em-
phasis has been given to the evaluation of the implemen-
tation strategies, which is a critical component
underpinning effectiveness, particularly regarding com-
plex and behavioral driven interventions. Our ambition
is to implement a multifaceted intervention targeted at
women, healthcare professionals, and organizations sim-
ultaneously. The study will generate evidence on the
feasibility, acceptability, implementation, effectiveness,
and equity of this intervention to reduce overuse of CS
in various settings in LMICs and on approaches to over-
come barriers to implementation. Our project will go be-
yond the state of the art for the following reasons. First,
it will provide an exhaustive description of the barriers
and facilitators to implementing the four components of
the QUALI-DEC intervention in various settings under a
rigorous formative research phase [19]. This information
will help identify and systematically structure-specific
determinants associated with implementation success.
This is particularly true for the implementation of com-
panionship during labor and evidence-based clinical
practice guidelines combined with A&F and opinion
leaders. Second, it will help explain what influences im-
plementation outcomes and provide information on the
overuse of CS in settings where the performance in
terms of CS decision-making is currently undocu-
mented. Third, it will integrate qualitative and quanti-
tative data to strengthen the internal validity of the
results. Combining the merits of multiple theoretical
approaches, the QUALI-DEC project will offer a more
complete understanding by providing a theory of
change that could be adapted to different settings
[29]. Fourth, it will analyze the scalability and trans-
ferability of the intervention to other contexts, a
pressing issue considering the global rise in CS in the
past few decades. Importantly, QUALI-DEC focuses
on LMICs, where addressing the challenge of overuse
has become a priority.
In conclusion, the findings from this pragmatic evalu-
ation will be highly applicable to practitioners, service
managers, and policy-makers who are tasked with imple-
menting a nonclinical intervention to reduce unneces-
sary CS in LMICs. In addition, the findings will
determine the effectiveness and cost-effectiveness of an
innovative implementation strategy tailored to the needs
of the local setting. This strategy aims to implement four
active components that are expected to improve quality
decision-making for the mode of birth so that only the
women who need to have a CS undergo the procedure.
The strategy will involve women, healthcare profes-
sionals, and organizations and will focus on how to best
and most effectively implement these components, con-
sidering the local needs and resources in each country.
Overall, our project will improve the appropriate use of
CS and address several sustainable development goal tar-
gets, including improving maternal and neonatal health
and reducing inequalities within and between countries.
Supplementary information
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1186/s13012-020-01029-4.
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